Two 64-year-old men were referred to our unit for the devel- opment of a cutaneous manifestation, during the 4th cycle of treatment with tebentafusp for liver metastases from uveal melanomas

Drug-induced photosensitivity during tebentafusp treatment for metastatic uveal melanoma: A newly described occurrence / Lambertini M.; Comito F.; Melotti B.; Baracca M.F.; Dika E.. - In: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. - ISSN 0926-9959. - ELETTRONICO. - 37:2(2023), pp. e207-e208. [10.1111/jdv.18625]

Drug-induced photosensitivity during tebentafusp treatment for metastatic uveal melanoma: A newly described occurrence

Lambertini M.
Primo
Writing – Original Draft Preparation
;
Comito F.
Membro del Collaboration Group
;
Baracca M. F.
Membro del Collaboration Group
;
Dika E.
Ultimo
Writing – Review & Editing
2023

Abstract

Two 64-year-old men were referred to our unit for the devel- opment of a cutaneous manifestation, during the 4th cycle of treatment with tebentafusp for liver metastases from uveal melanomas
2023
Drug-induced photosensitivity during tebentafusp treatment for metastatic uveal melanoma: A newly described occurrence / Lambertini M.; Comito F.; Melotti B.; Baracca M.F.; Dika E.. - In: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. - ISSN 0926-9959. - ELETTRONICO. - 37:2(2023), pp. e207-e208. [10.1111/jdv.18625]
Lambertini M.; Comito F.; Melotti B.; Baracca M.F.; Dika E.
File in questo prodotto:
File Dimensione Formato  
tebentafusp.doc jeadv 2022.pdf

accesso riservato

Tipo: Versione (PDF) editoriale
Licenza: Licenza per accesso riservato
Dimensione 491.23 kB
Formato Adobe PDF
491.23 kB Adobe PDF   Visualizza/Apri   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/904311
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact